100M+ medical sources synthesized into evidence-graded, citation-backed answers for clinicians.
Synthesizing evidence from the world’s leading journals & databases
A new study is published every 26 seconds. Traditional search tools retrieve articles. Distill understands them — synthesizing across 100M+ sources of internalized medical knowledge to produce answers no simple retrieval system can match.
Access evidence from every clinical field
Not a simple search engine. Distill's AI has internalized 100M+ medical sources — textbooks, guidelines, Cochrane reviews, and the complete PubMed corpus. It reasons across the full depth of medical knowledge, not just retrieved snippets.
Every claim is cited. Every reference links to PubMed. Evidence levels (I–IV) are assigned automatically. You always know the strength of the evidence.
No drug ads during clinical queries. No sponsored content. No pharma-funded revenue. Other platforms show targeted pharmaceutical ads while you wait for answers — at CPMs up to $1,000. Distill will never sell access to the moment of clinical decision-making.
Some platforms offer free clinical AI tools — then monetize the moment of clinical decision-making by selling pharma ad placements targeted to your specialty while you wait for an answer. Distill is built differently.
Our position: If a platform’s revenue depends on pharmaceutical companies believing that ads shown during clinical decision-making change prescribing behavior — then the platform’s incentives are fundamentally misaligned with evidence-based medicine. Distill exists because clinicians deserve better.
ChatGPT is a general-purpose assistant. Distill is a purpose-built clinical evidence engine — its AI has internalized the equivalent of every medical textbook, 100M+ peer-reviewed sources, and the complete PubMed/FDA corpus. Every answer is evidence-graded with citations linking directly to primary sources. It doesn’t guess. It synthesizes.
OpenEvidence relies on an ensemble of smaller custom models that retrieve and summarize articles. Distill uses the most advanced reasoning AI available — one that has internalized the full breadth of medical literature, not just what it retrieves per query. The result is deeper synthesis, better cross-referencing, and clinical insights that simple retrieval-based systems miss. Plus: zero pharmaceutical advertising, and open to all clinicians worldwide.
Every claim is grounded in cited evidence with Level I–IV classification. Distill’s AI doesn’t hallucinate — it synthesizes from internalized medical knowledge cross-referenced with real-time PubMed data. When evidence is insufficient or conflicting, it tells you explicitly rather than generating a confident-sounding guess.
All healthcare professionals — physicians, residents, NPs, PAs, pharmacists, nurses, and medical students worldwide.
Your queries are stored encrypted and never used for model training. Uploaded documents are automatically deleted after 24 hours. We do not sell data to third parties or pharmaceutical companies. See our privacy policy for details.
Distill is expanding to meet you wherever clinical decisions happen.
Evidence-graded answers at the bedside, in the OR, or on rounds. Native mobile apps with offline access to guidelines and instant voice queries.
Attach lab values, radiology reports, pathology images, or clinical photos. Distill’s multimodal AI analyzes them in context with the evidence base — turning raw data into actionable clinical intelligence.
No pharmaceutical advertising. No hidden costs. Cancel anytime.
For clinicians exploring evidence-based AI.
or $119.99/year (save 33%)
For clinicians who rely on evidence daily.
$99.99/seat/year · 5 seat minimum
For departments, residency programs, and practices.
100M+ sources. Real-time evidence triangulation. Zero pharmaceutical influence. Start for free.